Optimizing resection for "responding" hepatic metastases after neoadjuvant chemotherapy.

Area of Science:

• Oncology
• Surgical Oncology
• Hepatobiliary Surgery

Background:

• Colorectal cancer frequently metastasizes to the liver, affecting 50% of patients.
• Recent therapeutic advances are shifting the treatment paradigm for metastatic colorectal cancer.
• Hepatic metastases represent a significant challenge in colorectal cancer management.

Purpose of the Study:

• To review the surgical management of hepatic colorectal metastases.
• To discuss treatment strategies for patients responding to neoadjuvant chemotherapy.
• To address the complexities of managing "disappearing" colorectal liver metastases.

Main Methods:

• Literature review focusing on surgical management.
• Analysis of treatment outcomes for neoadjuvant chemotherapy responders.
• Discussion of clinical challenges and potential solutions.

Main Results:

• Neoadjuvant chemotherapy can induce significant tumor response in hepatic colorectal metastases.
• Surgical resection remains a key treatment modality for selected patients.
• Management of "disappearing" metastases requires careful consideration and multidisciplinary approach.

Conclusions:

• Surgical management of hepatic colorectal metastases is evolving.
• Response to neoadjuvant chemotherapy impacts surgical decision-making.
• Further research is needed to optimize treatment for "disappearing" metastases.